Resource library


See all videos


iBiopsy®: Artificial Intelligence is our DNA

See all brochures

White papers

Understanding Novel Response Patterns of Immunotherapies

Immunotherapies display novel response patterns that affect the design of imaging based studies and the subsequent evaluation of imaging data. Applying traditional chemotherapy-based response assumptions to immunotherapy trials can result in inaccurate interpretation of response, premature therapy termination, and unnecessary removal of subjects from a trial. Our unique solutions for medical image analysis and management and iBiopsy® for imaging phenotyping, together with our global team of experts, are advancing the development of new drugs and diagnostic tools to monitor disease and assess response to therapy.

See all white papers

Case studies

How automation can improve data consistency/value, and streamline study workflow

See all case studies

Scientific publications

Development of an AI/ML Tech Based Pulmonary Nodule Malignancy Prediction Model: Application to Indeterminate Pulmonary Nodules (IPN)* and Early Stage Cancers

Charles Voyton [1], Pierre Baudot [1], Van Khoa Le [1], Danny Francis [1], Elias Munoz [1], Yan Liu [1], Benoit Huet [1] – Affiliations: [1] Median Technologies, 1800 Route des Crêtes, 06560 Valbonne, France.

Presentation held at RSNA 2022 AI Theater on November 29, 2022

See all scientific publications